Current advances in the imaging of atherosclerotic vulnerable plaque using nanoparticles
Source abstract
Abstract
Vulnerable atherosclerotic plaques of the artery wall that pose a significant risk of cardio-cerebral vascular accidents remain the global leading cause of morbidity and mortality. Thus, early delineation of vulnerable atherosclerotic plaques is of clinical importance for prevention and treatment. The currently available imaging technologies mainly focus on the structural assessment of the vascular wall. Unfortunately, several disadvantages in these strategies limit the improvement in imaging effect. Nanoparticle technology is a novel diagnostic strategy for targeting and imaging pathological biomarkers. New functionalized nanoparticles that detect hallmarks of vulnerable plaques are promising for advance further control of this critical illness. The review aims to address the current opportunities and challenges for the use of nanoparticle technology in imagining vulnerable plaques.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Cerebrovascular and Carotid Artery Diseases · Cardiovascular Disease and Adiposity · Cardiac Imaging and Diagnostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Libby · Atherosclerosis, Nature Rev. Dis. primers · 2019 · 5 · 5610.1038/s41572-019-0106-z ↗
2. Grant · Eur. Heart J. · 2019 · 40 · 321510.1093/eurheartj/ehz687 ↗
3. Heart disease and stroke statistics-2020 update: a report from the American heart association10.1161/CIR.0000000000000757 ↗
4. Predictors of rapid plaque progression: an optical coherence tomography study10.1016/j.jcmg.2020.08.014 ↗
5. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction10.1001/jama.2011.522 ↗
6. The immunology of atherosclerosis, Nature reviews
7. Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study)
8. Acute coronary events10.1161/CIRCULATIONAHA.111.047431 ↗
9. The myth of 'stable' coronary artery disease, Nature reviews
10. Neutrophil extracellular traps induce endothelial cell activation and tissue factor production through interleukin-1α and cathepsin G10.1161/ATVBAHA.118.311150 ↗
11. Mechanisms of plaque formation and rupture10.1161/CIRCRESAHA.114.302721 ↗
12. The molecular basis of predicting atherosclerotic cardiovascular disease risk10.1161/CIRCRESAHA.120.315890 ↗
13. Thrombosis formation on atherosclerotic lesions and plaque rupture10.1111/joim.12296 ↗
14. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology10.1161/01.CIR.89.1.36 ↗
15. Moderate hypoxia potentiates interleukin-1β production in activated human macrophages10.1161/CIRCRESAHA.115.304437 ↗
16. Melatonin stabilizes rupture-prone vulnerable plaques via regulating macrophage polarization in a nuclear circadian receptor RORα-dependent manner10.1111/jpi.12581 ↗
17. Pro-inflammatory cytokines in acute coronary syndromes10.2174/1381612826666200413082353 ↗
18. Reassessing the mechanisms of acute coronary syndromes10.1161/CIRCRESAHA.118.311098 ↗
19. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture10.1016/0735-1097(94)90657-2 ↗
20. Serum MMP-9 diagnostics, prognostics, and activation in acute coronary syndrome and its recurrence10.1007/s12265-018-9789-x ↗
21. Matrix metalloproteinase-13 predominates over matrix metalloproteinase-8 as the functional interstitial collagenase in mouse atheromata10.1161/ATVBAHA.114.303326 ↗
22. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques10.1172/JCI117619 ↗
23. Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death10.1161/01.CIR.80.6.1747 ↗
24. Basement membranes: structure, assembly and role in tumour angiogenesis10.1038/nrc1094 ↗
25. New insight into biology, molecular diagnostics and treatment options of unstable carotid atherosclerotic plaque: a narrative review10.21037/atm-20-7197 ↗
26. Collagen types in various layers of the human aorta and their changes with the atherosclerotic process10.1016/0021-9150(86)90172-3 ↗
27. Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stage10.1161/CIRCULATIONAHA.108.806158 ↗
28. Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress10.1016/j.cmet.2010.09.010 ↗
29. Macrophages in the pathogenesis of atherosclerosis10.1016/j.cell.2011.04.005 ↗
30. Inhibition of PFKFB3 hampers the progression of atherosclerosis and promotes plaque stability10.3389/fcell.2020.581641 ↗
31. Deletion or inhibition of NOD1 favors plaque stability and attenuates atherothrombosis in advanced atherogenesis10.3390/cells9092067 ↗
32. Coronary artery calcification and its progression: what does it really mean?, JACC
33. Natural history and histological classification of atherosclerotic lesions: an update10.1161/01.ATV.20.5.1177 ↗
34. [F]-NaF PET/CT identifies active calcification in carotid plaque, JACC
35. Role of coronary artery calcium score in the primary prevention of cardiovascular disease
36. Dynamic change of carotid intraplaque hemorrhage volume in subjects with mild carotid stenosis10.1016/j.ejrad.2018.05.018 ↗
37. New insights into the role of iron in inflammation and atherosclerosis10.1016/j.ebiom.2019.08.014 ↗
38. Prediction of stroke risk by detection of hemorrhage in carotid plaques: meta-analysis of individual patient data10.1016/j.jcmg.2019.03.028 ↗
39. Communication of inwardly projecting neovessels with the lumen contributes to symptomatic intraplaque hemorrhage in carotid artery stenosis10.3171/2014.12.JNS142371 ↗
40. Fibroblast growth factor-2/platelet-derived growth factor enhances atherosclerotic plaque stability10.1111/jcmm.14850 ↗
41. Angiogenesis in the atherosclerotic plaque10.1016/j.redox.2017.01.007 ↗
42. Plaque neovascularization detected with contrast-enhanced ultrasound predicts ischaemic stroke recurrence in patients with carotid atherosclerosis10.1111/ene.14157 ↗
43. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles10.1161/01.CIR.0000093185.16083.95 ↗
44. Myricitrin inhibits vascular endothelial growth factor-induced angiogenesis of human umbilical vein endothelial cells and mice10.1016/j.biopha.2020.110726 ↗
45. Active targeting of early and mid-stage atherosclerotic plaques using self-assembled peptide amphiphile micelles10.1016/j.biomaterials.2014.06.054 ↗
46. Endothelial vascular cell adhesion molecule 1 is a marker for high-risk carotid plaques and target for ultrasound molecular imaging10.1016/j.jvs.2017.10.088 ↗
47. A peripheral blood gene expression score is associated with atherosclerotic Plaque Burden and Stenosis by cardiovascular CT-angiography: results from the PREDICT and COMPASS studies10.1016/j.atherosclerosis.2013.12.045 ↗
48. Comparison of coronary atherosclerotic plaque burden and composition as assessed on coronary computed tomography angiography in east asian and European-origin caucasians10.1016/j.amjcard.2019.06.020 ↗
49. Calcification remodeling index characterized by cardiac CT as a novel parameter to predict the use of rotational atherectomy for coronary intervention of lesions with moderate to severe calcification10.3348/kjr.2017.18.5.753 ↗
50. Acute kidney injury after computed tomography: a meta-analysis10.1016/j.annemergmed.2017.06.041 ↗
51. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome10.1016/j.jacc.2009.02.068 ↗
52. Contemporary carotid imaging: from degree of stenosis to plaque vulnerability10.3171/2015.1.JNS142452 ↗
53. Dynamic contrast-enhanced MR imaging of carotid atherosclerotic plaque: model selection, reproducibility, and validation10.1148/radiol.12120499 ↗
54. Identification of high-risk carotid plaque with MRI-based radiomics and machine learning10.1007/s00330-020-07361-z ↗
55. Relationship between carotid plaque surface morphology and perfusion: a 3D DCE-MRI study10.1007/s10334-017-0621-4 ↗
56. Diagnostic accuracy of a clinical carotid plaque MR protocol using a neurovascular coil compared to a surface coil protocol10.1002/jmri.25984 ↗
57. Multispectral diffusion-weighted imaging near metal implants10.1002/mrm.26737 ↗
58. Advances in IVUS/OCT and future clinical perspective of novel hybrid catheter system in coronary imaging10.3389/fcvm.2020.00119 ↗
59. Longitudinal distribution of plaque burden and necrotic core-rich plaques in nonculprit lesions of patients presenting with acute coronary syndromes, JACC
60. Does calcium burden impact culprit lesion morphology and clinical results? An ADAPT-DES IVUS substudy10.1016/j.ijcard.2017.08.028 ↗
61. Fluorescence lifetime imaging combined with conventional intravascular ultrasound for enhanced assessment of atherosclerotic plaques: an ex vivo study in human coronary arteries10.1007/s12265-015-9627-3 ↗
62. IVUS-guided versus OCT-guided coronary stent implantation: a critical appraisal, JACC
63. Sources of error and interpretation of plaque morphology by optical coherence tomography10.1016/j.amjcard.2006.01.097 ↗
64. Optical coherence tomography: fundamentals and clinical utility10.21037/cdt-20-253 ↗
65. Molecular imaging of pulmonary fibrosis: another step forward10.1164/rccm.202007-2897ED ↗
66. Early detection of pancreatic cancer, the lancet
67. Coronary arterial 18F-FDG uptake by fusion of PET and coronary CT angiography at sites of percutaneous stenting for acute myocardial infarction and stable coronary artery disease10.2967/jnumed.111.097550 ↗
68. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial10.1016/S0140-6736(13)61754-7 ↗
69. PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis, JACC
70. Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques, European heart journal
71. Molecular imaging of matrix metalloproteinase expression in atherosclerotic plaques of mice deficient in apolipoprotein e or low-density-lipoprotein receptor10.2967/jnumed.108.055889 ↗
72. Association of biologic therapy with coronary inflammation in patients with psoriasis as assessed by perivascular fat attenuation index10.1001/jamacardio.2019.2589 ↗
73. PET/CT imaging of unstable carotid plaque with 68 Ga-labeled somatostatin receptor ligand10.2967/jnumed.116.181438 ↗
74. Impact of respiratory motion correction and spatial resolution on lesion detection in PET: a simulation study based on real MR dynamic data10.1088/0031-9155/59/3/697 ↗
75. Correction of respiratory and cardiac motion in cardiac PET/MR using MR-based motion modeling10.1088/1361-6560/aaea97 ↗
76. Innovations in instrumentation for positron emission tomography10.1053/j.semnuclmed.2018.02.006 ↗
77. Hybrid FDG-PET/MR or FDG-PET/CT to detect disease activity in patients with persisting arrhythmias after myocarditis10.1016/j.jcmg.2020.03.009 ↗
78. PET/MRI: where might it replace PET/CT?10.1002/jmri.25711 ↗
79. Consensus on molecular imaging and theranostics in prostate cancer, the Lancet
80. DNA nanotechnology-empowered nanoscopic imaging of biomolecules10.1039/D0CS01281E ↗
81. Paramagnetic and superparamagnetic inorganic nanoparticles for T1-weighted magnetic resonance imaging10.2174/0929867324666170314124616 ↗
82. Magnetic nanoparticles coated with polyphenols for spatio-temporally controlled cancer photothermal/immunotherapy10.1016/j.jconrel.2020.06.015 ↗
83. Mitigation of inflammatory immune responses with hydrophilic nanoparticles10.1002/anie.201710068 ↗
84. Metal-chelating polymers (MCPs) with zwitterionic pendant groups complexed to trastuzumab exhibit decreased liver accumulation compared to polyanionic MCP immunoconjugates10.1021/acs.biomac.5b01066 ↗
85. Charge-reversal biodegradable MSNs for tumor synergetic chemo/photothermal and visualized therapy10.1016/j.jconrel.2021.09.005 ↗
86. Effect of surface-functionalized nanoparticles on the elongation phase of beta-amyloid (1-40) fibrillogenesis10.1016/j.biomaterials.2012.03.024 ↗
87. Nanoparticle toxicology10.1146/annurev-pharmtox-032320-110338 ↗
88. A non-invasive nanoprobe for in vivo photoacoustic imaging of vulnerable atherosclerotic plaque10.1002/adma.202000037 ↗
89. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques10.1161/hc3601.094303 ↗
90. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly10.1056/NEJM199705013361802 ↗
91. Critical cap thickness and rupture in symptomatic carotid plaques: the oxford plaque study10.1161/STROKEAHA.107.507988 ↗
92. Reproducibility of fibrous cap status assessment of carotid artery plaques by contrast-enhanced MRI10.1161/STROKEAHA.109.555052 ↗
93. Quercetin attenuates atherosclerotic inflammation by inhibiting galectin-3-NLRP3 signaling pathway10.1002/mnfr.202000746 ↗
94. Utility of USPIO-enhanced MR imaging to identify inflammation and the fibrous cap: a comparison of symptomatic and asymptomatic individuals10.1016/j.ejrad.2008.01.047 ↗
95. The in vivo radiosensitizing effect of gold nanoparticles based MRI contrast agents10.1002/smll.201302303 ↗
96. Direct imaging of cerebral thromboemboli using computed tomography and fibrin-targeted gold nanoparticles10.7150/thno.11679 ↗
97. Senescent intimal foam cells are deleterious at all stages of atherosclerosis10.1126/science.aaf6659 ↗
98. Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis10.1038/s41565-019-0619-3 ↗
99. Nanoparticle-based approaches towards the treatment of atherosclerosis10.3390/pharmaceutics12111056 ↗
100. Melatonin inhibits macrophage infiltration and promotes plaque stabilization by upregulating anti-inflammatory HGF/c-Met system in the atherosclerotic rabbit: USPIO-enhanced MRI assessment10.1016/j.vph.2020.106659 ↗